Tapewire

Nasdaq · USD

TLSA

Tiziana Life Sciences Ltd

Export transactions ↓
Tapewire entity
6639
SEC CIK
0001723069
Parsed reports
10

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202610
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2026 Filed Sep 29, 2026 21:13 UTC
Elrifi IvorChief Executive Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,050,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-104755 · ownership.xml · derivative · entry 2

Elrifi Ivor · CIK 0002136241 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100,000

Underlying: COMMON STOCK · 1,050,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.

F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.

F2 · derivative.expiration_date: The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.

Read SEC document
August 15, 2026 Filed Sep 29, 2026 21:13 UTC
Elrifi IvorChief Executive Officer
Exercise / conversionCOMMON STOCK 1,050,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-104755 · ownership.xml · nonDerivative · entry 1

Elrifi Ivor · CIK 0002136241 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 5,843,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock.

Read SEC document
August 05, 2026 Filed Aug 6, 2026 13:30 UTC
Elrifi IvorChief Executive Officer
PurchaseCOMMON STOCK 237,616 $1.00 $237,616.00
Disclosure

SEC source: 0001213900-26-085950 · ownership.xml · nonDerivative · entry 2

Elrifi Ivor · CIK 0002136241 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 4,793,684

Read SEC document
August 04, 2026 Filed Aug 6, 2026 13:30 UTC
Elrifi IvorChief Executive Officer
PurchaseCOMMON STOCK 83,807 $0.97 $81,292.79
Disclosure

SEC source: 0001213900-26-085950 · ownership.xml · nonDerivative · entry 1

Elrifi Ivor · CIK 0002136241 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 4,556,068

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:30 UTC
Elrifi IvorChief Executive Officer
PurchaseCOMMON STOCK 667,000 $1.00 $667,000.00
Disclosure

SEC source: 0001213900-26-085710 · ownership.xml · nonDerivative · entry 1

Elrifi Ivor · CIK 0002136241 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust

Disclosed balance after: 4,472,261

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:15 UTC
CERRONE GABRIELE MDirector · 10% owner
GrantCOMMON STOCK 42,357 $0.99 $41,933.43
Disclosure

SEC source: 0001213900-26-080880 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 44,814,587

Read SEC document
July 21, 2026 Filed Aug 7, 2026 20:16 UTC Amendment
CERRONE GABRIELE MDirector · 10% owner
PurchaseCOMMON STOCK 42,357 $0.99 $41,933.43
Disclosure

SEC source: 0001213900-26-086697 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 44,814,587

Read SEC document
June 12, 2026 Filed Jun 17, 2026 10:31 UTC
CERRONE GABRIELE MDirector · 10% owner
GrantCOMMON STOCK 15,000 $1.11 $16,650.00
Disclosure

SEC source: 0001213900-26-069424 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 44,772,230

Read SEC document
June 12, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
CERRONE GABRIELE MDirector · 10% owner
PurchaseCOMMON STOCK 15,000 $1.11 $16,650.00
Disclosure

SEC source: 0001213900-26-086696 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 44,772,230

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.